Thus, Wnt10b signaling might act as a suppressor of CIN that is a well-established driving force for the generation of high genetic heterogeneity and variability in cancer supporting tumor evolution toward aggressive growth phenotypes, metastasis, and therapy resistance (Sansregret et al, 2018; Chen et al, 2025). This evidence concerns the gene WNT10B and neoplasm.